118 related articles for article (PubMed ID: 20506334)
41. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
Jabs DA; Enger C; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
[TBL] [Abstract][Full Text] [Related]
42. Sex differences in a murine model of Sjögren's syndrome.
Ciháková D; Talor MV; Barin JG; Baldeviano GC; Fairweather D; Rose NR; Burek CL
Ann N Y Acad Sci; 2009 Sep; 1173():378-83. PubMed ID: 19758176
[TBL] [Abstract][Full Text] [Related]
43. Rituximab therapy in primary Sjögren's syndrome.
Alcântara C; Gomes MJ; Ferreira C
Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218
[TBL] [Abstract][Full Text] [Related]
44. Different La/SS-B mRNA isoforms are expressed in salivary gland tissue of patients with primary Sjögren's syndrome.
Bachmann M; Hilker M; Grölz D; Tellmann G; Hake U; Kater L; de Wilde P; Tröster H
J Autoimmun; 1996 Dec; 9(6):757-66. PubMed ID: 9115578
[TBL] [Abstract][Full Text] [Related]
45. Autoantibody production in Sjögren's syndrome: a hypothesis regarding defects in somatic diversification of germ line encoded genes.
Fox RI; Fong S; Chen PP; Kipps TJ
In Vivo; 1988; 2(1):47-55. PubMed ID: 2979816
[TBL] [Abstract][Full Text] [Related]
46. Role of dendritic cells in Sjögren's syndrome.
Vogelsang P; Jonsson MV; Dalvin ST; Appel S
Scand J Immunol; 2006 Sep; 64(3):219-26. PubMed ID: 16918690
[TBL] [Abstract][Full Text] [Related]
47. A novel NOD-derived murine model of primary Sjögren's syndrome.
Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
[TBL] [Abstract][Full Text] [Related]
48. DNA hypermethylation leads to lower FOXP3 expression in CD4+ T cells of patients with primary Sjögren's syndrome.
Yu X; Liang G; Yin H; Ngalamika O; Li F; Zhao M; Lu Q
Clin Immunol; 2013 Aug; 148(2):254-7. PubMed ID: 23773924
[No Abstract] [Full Text] [Related]
49. Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
Blokland SLM; Hillen MR; Wichers CGK; Zimmermann M; Kruize AA; Radstake TRDJ; Broen JCA; van Roon JAG
RMD Open; 2019; 5(1):e000701. PubMed ID: 30713717
[No Abstract] [Full Text] [Related]
50. Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.
Nezos A; Mavragani CP
J Immunol Res; 2015; 2015():754825. PubMed ID: 26550578
[TBL] [Abstract][Full Text] [Related]
51. Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome.
Naito Y; Matsumoto I; Wakamatsu E; Goto D; Ito S; Tsutsumi A; Sumida T
Ann Rheum Dis; 2006 Feb; 65(2):269-71. PubMed ID: 16410534
[No Abstract] [Full Text] [Related]
52. What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?
Peck AB; Nguyen CQ
Clin Immunol; 2017 Sep; 182():14-23. PubMed ID: 28478104
[TBL] [Abstract][Full Text] [Related]
53. Sjogren's syndrome: New paradigms and areas for future research.
Ambrus JL
Clin Immunol; 2017 Sep; 182():1-3. PubMed ID: 28673862
[No Abstract] [Full Text] [Related]
54. Targeted deletion of the gene encoding the La autoantigen (Sjögren's syndrome antigen B) in B cells or the frontal brain causes extensive tissue loss.
Gaidamakov S; Maximova OA; Chon H; Blewett NH; Wang H; Crawford AK; Day A; Tulchin N; Crouch RJ; Morse HC; Blitzer RD; Maraia RJ
Mol Cell Biol; 2014 Jan; 34(1):123-31. PubMed ID: 24190965
[TBL] [Abstract][Full Text] [Related]
55. Protective role of commensal bacteria in Sjögren Syndrome.
Zaheer M; Wang C; Bian F; Yu Z; Hernandez H; de Souza RG; Simmons KT; Schady D; Swennes AG; Pflugfelder SC; Britton RA; de Paiva CS
J Autoimmun; 2018 Sep; 93():45-56. PubMed ID: 29934134
[TBL] [Abstract][Full Text] [Related]
56. IDD3 and IDD5 alleles from nod mice mediate Sjögren's syndrome-like autoimmunity.
Cha S; Nagashima H; Peck AB; Humphreys-Beher MG
Adv Exp Med Biol; 2002; 506(Pt B):1035-9. PubMed ID: 12614028
[No Abstract] [Full Text] [Related]
57. Modeling Sjögren's syndrome with Id3 conditional knockout mice.
Guo Z; Li H; Han M; Xu T; Wu X; Zhuang Y
Immunol Lett; 2011 Mar; 135(1-2):34-42. PubMed ID: 20932862
[TBL] [Abstract][Full Text] [Related]
58. Sjögren syndrome: advances in the pathogenesis from animal models.
Chiorini JA; Cihakova D; Ouellette CE; Caturegli P
J Autoimmun; 2009; 33(3-4):190-6. PubMed ID: 19800762
[TBL] [Abstract][Full Text] [Related]
59. New insights into ADAMs regulation of the GRO-α/CXCR2 system: focus on Sjögren's syndrome.
Sisto M; Lisi S
Int Rev Immunol; 2015; 34(6):486-99. PubMed ID: 25386842
[TBL] [Abstract][Full Text] [Related]
60. B cells clonality and primary Sjögren's syndrome: comment on the article by Arvidsson et al.
Mahla RS
Arthritis Rheumatol; 2024 Feb; 76(2):313-314. PubMed ID: 37691295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
